Literature DB >> 22931899

Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza.

Lenee Blanton1, Georgina Peacock, Chad Cox, Michael Jhung, Lyn Finelli, Cynthia Moore.   

Abstract

OBJECTIVE: The goal of this study was to describe reported influenza A (H1N1)pdm09 virus (pH1N1)-associated deaths in children with underlying neurologic disorders.
METHODS: The study compared demographic characteristics, clinical course, and location of death of pH1N1-associated deaths among children with and without underlying neurologic disorders reported to the Centers for Disease Control and Prevention.
RESULTS: Of 336 pH1N1-associated pediatric deaths with information on underlying conditions, 227 (68%) children had at least 1 underlying condition that conferred an increased risk of complications of influenza. Neurologic disorders were most frequently reported (146 of 227 [64%]), and, of those disorders, neurodevelopmental disorders such as cerebral palsy and intellectual disability were most common. Children with neurologic disorders were older (P = .02), had a significantly longer duration of illness from onset to death (P < .01), and were more likely to die in the hospital versus at home or in the emergency department (P < .01) compared with children without underlying medical conditions. Many children with neurologic disorders had additional risk factors for influenza-related complications, especially pulmonary disorders (48%). Children without underlying conditions were significantly more likely to have a positive result from a sterile-site bacterial culture than were those with an underlying neurologic disorder (P < .01).
CONCLUSIONS: Neurologic disorders were reported in nearly two-thirds of pH1N1-associated pediatric deaths with an underlying medical condition. Because of the potential for severe outcomes, children with underlying neurologic disorders should receive influenza vaccine and be treated early and aggressively if they develop influenza-like illness.

Entities:  

Mesh:

Year:  2012        PMID: 22931899     DOI: 10.1542/peds.2011-3343

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Influenza vaccination in children with neurologic or neurodevelopmental disorders.

Authors:  Michael Smith; Georgina Peacock; Timothy M Uyeki; Cynthia Moore
Journal:  Vaccine       Date:  2015-03-30       Impact factor: 3.641

2.  The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary.

Authors:  Upton D Allen
Journal:  Paediatr Child Health       Date:  2013-03       Impact factor: 2.253

Review 3.  Vaccination in people with disability: a review.

Authors:  Jenny O'Neill; Fiona Newall; Giuliana Antolovich; Sally Lima; Margie Danchin
Journal:  Hum Vaccin Immunother       Date:  2019-07-24       Impact factor: 3.452

Review 4.  Influenza vaccination and treatment in children with neurologic disorders.

Authors:  Fiona Havers; Alicia Fry; Georgina Peacock; Lyn Finelli
Journal:  Ther Adv Vaccines       Date:  2014-07

5.  Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014.

Authors:  Brendan Flannery; Sue B Reynolds; Lenee Blanton; Tammy A Santibanez; Alissa O'Halloran; Peng-Jun Lu; Jufu Chen; Ivo M Foppa; Paul Gargiullo; Joseph Bresee; James A Singleton; Alicia M Fry
Journal:  Pediatrics       Date:  2017-04-03       Impact factor: 7.124

6.  The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013.

Authors:  Fred Y Aoki; Upton D Allen; H Grant Stiver; Gerald A Evans
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

7.  Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007.

Authors:  Talia M Quandelacy; Cecile Viboud; Vivek Charu; Marc Lipsitch; Edward Goldstein
Journal:  Am J Epidemiol       Date:  2013-11-04       Impact factor: 4.897

8.  Infection control assessment after an influenza outbreak in a residential care facility for children and young adults with neurologic and neurodevelopmental conditions.

Authors:  Alejandro Azofeifa; Lorraine F Yeung; Georgina Peacock; Cynthia A Moore; Loren Rodgers; Mary DiOrio; Shannon L Page; Brian Fowler; Nimalie D Stone; Lyn Finelli; Michael A Jhung
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05-21       Impact factor: 3.254

9.  Influenza-associated pediatric deaths in the United States, 2004-2012.

Authors:  Karen K Wong; Seema Jain; Lenee Blanton; Rosaline Dhara; Lynnette Brammer; Alicia M Fry; Lyn Finelli
Journal:  Pediatrics       Date:  2013-10-28       Impact factor: 7.124

10.  Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children.

Authors:  James W Antoon; Matt Hall; Alison Herndon; David P Johnson; Charlotte M Brown; Whitney L Browning; Todd A Florin; Leigh M Howard; Carlos G Grijalva; Derek J Williams
Journal:  J Pediatr       Date:  2021-07-01       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.